Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
出版年份 2020 全文链接
标题
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 31, Pages 18754-18763
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-07-21
DOI
10.1073/pnas.2008236117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women
- (2020) Mark D. Pankau et al. PLoS Pathogens
- Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti–HIV-1 IgG1 antibodies in vivo
- (2020) Pengfei Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Establishment of A Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs
- (2019) Nina C. Flerin et al. JOURNAL OF VIROLOGY
- Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
- (2019) Cordelia Manickam et al. Frontiers in Immunology
- The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation
- (2019) Melissa-Rose Abrahams et al. Science Translational Medicine
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
- (2018) Yotam Bar-On et al. NATURE MEDICINE
- Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
- (2018) Matthew S. Parsons et al. JOURNAL OF CLINICAL INVESTIGATION
- Addendum: Immune clearance of highly pathogenic SIV infection
- (2017) Scott G. Hansen et al. NATURE
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Stochastic principles governing alternative splicing of RNA
- (2017) Jianfei Hu et al. PLoS Computational Biology
- Multiple Origins of Virus Persistence during Natural Control of HIV Infection
- (2016) Eli A. Boritz et al. CELL
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
- (2016) Hui Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL
- (2014) J. A. Woyach et al. BLOOD
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
- (2014) Stylianos Bournazos et al. CELL
- Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
- (2014) Ariel Halper-Stromberg et al. CELL
- Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo
- (2014) R. S. Rudicell et al. JOURNAL OF VIROLOGY
- Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
- (2013) Marcella Sarzotti-Kelsoe et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced Fc RIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
- (2012) B. Moldt et al. JOURNAL OF VIROLOGY
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
- (2009) Ann J Hessell et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started